| 51 |
29256966 | Influence of donor liver CYP3A4*20 loss-of-function genotype on tacrolimus pharmacokinetics in transplanted patients. | 2018 Feb |
4 |
| 52 |
29469606 | Detection of a rare CYP3A4 variant in a transplant patient characterized by a tacrolimus poor metabolizer phenotype. | 2018 Mar |
1 |
| 53 |
29546446 | CYP3A4 and GCK genetic polymorphisms are the risk factors of tacrolimus-induced new-onset diabetes after transplantation in renal transplant recipients. | 2018 Jun |
3 |
| 54 |
29547545 | Prediction of Tacrolimus Exposure by CYP3A5 Genotype and Exposure of Co-Administered Everolimus in Japanese Renal Transplant Recipients. | 2018 Mar 16 |
2 |
| 55 |
29615122 | Effect of CYP3 A4, CYP3 A5 and ABCB1 gene polymorphisms on the clinical efficacy of tacrolimus in the treatment of nephrotic syndrome. | 2018 Apr 3 |
1 |
| 56 |
29629825 | CYP3A pharmacogenetic association with tacrolimus pharmacokinetics differs based on route of drug administration. | 2018 Apr |
3 |
| 57 |
29733390 | Increase in tacrolimus exposure after steroid tapering is influenced by CYP3A5 and pregnane X receptor genetic polymorphisms in renal transplant recipients. | 2018 Sep 1 |
2 |
| 58 |
29801578 | The Pharmacogenetics of Immune-Modulating Therapy. | 2018 |
1 |
| 59 |
29804290 | Tacrolimus Elimination in Four Patients With a CYP3A5*3/*3 CYP3A4*22/*22 Genotype Combination. | 2018 Jul |
4 |
| 60 |
29920787 | Genotypes associated with tacrolimus pharmacokinetics impact clinical outcomes in lung transplant recipients. | 2018 Aug |
3 |
| 61 |
30040022 | Tacrolimus population pharmacokinetic models according to CYP3A5/CYP3A4/POR genotypes in Chinese Han renal transplant patients. | 2018 Aug 1 |
1 |
| 62 |
30156148 | Individualized Tacrolimus Therapy for Pediatric Nephrotic Syndrome: Considerations for Ontogeny and Pharmacogenetics of CYP3A. | 2018 |
2 |
| 63 |
30166405 | Relationship between In Vivo CYP3A4 Activity, CYP3A5 Genotype, and Systemic Tacrolimus Metabolite/Parent Drug Ratio in Renal Transplant Recipients and Healthy Volunteers. | 2018 Nov |
2 |
| 64 |
30251601 | Influence of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics/Pharmacodynamics of Tacrolimus in Pediatric Patients. | 2018 |
2 |
| 65 |
27378609 | Effect of ABCB1 diplotype on tacrolimus disposition in renal recipients depends on CYP3A5 and CYP3A4 genotype. | 2017 Dec |
1 |
| 66 |
27822915 | Analysis of the variable factors influencing tacrolimus blood concentration during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantation. | 2017 Mar |
1 |
| 67 |
27890698 | Clementine juice has the potential for drug interactions - In vitro comparison with grapefruit and mandarin juice. | 2017 Jan 15 |
2 |
| 68 |
28008657 | Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance. | 2017 Jun |
1 |
| 69 |
28044353 | Donor CYP3A5 genotype influences tacrolimus disposition on the first day after paediatric liver transplantation. | 2017 Jun |
1 |
| 70 |
28050888 | A New CYP3A5*3 and CYP3A4*22 Cluster Influencing Tacrolimus Target Concentrations: A Population Approach. | 2017 Aug |
3 |
| 71 |
28146606 | The CYP3A biomarker 4β-hydroxycholesterol does not improve tacrolimus dose predictions early after kidney transplantation. | 2017 Jul |
3 |
| 72 |
28168728 | Response to: 'Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance'. | 2017 Jun |
1 |
| 73 |
28219593 | Betel Nut Chewing Is Associated With Reduced Tacrolimus Concentration in Taiwanese Liver Transplant Recipients. | 2017 Mar |
1 |
| 74 |
28229376 | The Pharmacogenetics of Tacrolimus in Corticosteroid-Sparse Pediatric and Adult Kidney Transplant Recipients. | 2017 Jun |
3 |
| 75 |
28324194 | Sex Differences in the Blood Concentration of Tacrolimus in Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients with CYP3A5*3/*3. | 2017 Jun |
1 |
| 76 |
28374426 | Response to: 'Response to: Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance'. | 2017 Jun |
1 |
| 77 |
28603840 | Pretransplant 4β-hydroxycholesterol does not predict tacrolimus exposure or dose requirements during the first days after kidney transplantation. | 2017 Nov |
1 |
| 78 |
28621555 | SLC28A3 rs7853758 as a new biomarker of tacrolimus elimination and new-onset hypertension in Chinese liver transplantation patients. | 2017 Aug |
2 |
| 79 |
28642710 | Tacrolimus Updated Guidelines through popPK Modeling: How to Benefit More from CYP3A Pre-emptive Genotyping Prior to Kidney Transplantation. | 2017 |
3 |
| 80 |
28655393 | The role of single nucleotide polymorphisms of CYP3A and ABCB1 on tacrolimus predose concentration in kidney transplant recipients. | 2017 Supplement 1 |
2 |
| 81 |
28704257 | The combination of CYP3A4*22 and CYP3A5*3 single-nucleotide polymorphisms determines tacrolimus dose requirement after kidney transplantation. | 2017 Sep |
1 |
| 82 |
28722255 | Drug-drug interactions between triazole antifungal agents used to treat invasive aspergillosis and immunosuppressants metabolized by cytochrome P450 3A4. | 2017 Oct |
1 |
| 83 |
28777242 | Analysis of common polymorphisms within NR1I2 and NR1I3 genes and tacrolimus dose-adjusted concentration in stable kidney transplant recipients. | 2017 Oct |
1 |
| 84 |
28945481 | Long-Term Influence of CYP3A5, CYP3A4, ABCB1, and NR1I2 Polymorphisms on Tacrolimus Concentration in Chinese Renal Transplant Recipients. | 2017 Nov |
3 |
| 85 |
29050276 | A new donors' CYP3A5 and recipients' CYP3A4 cluster predicting tacrolimus disposition, and new-onset hypertension in Chinese liver transplant patients. | 2017 Sep 19 |
1 |
| 86 |
26239045 | Impact of cytochrome P450 2C19 polymorphisms on the pharmacokinetics of tacrolimus when coadministered with voriconazole. | 2016 Apr |
1 |
| 87 |
26433738 | Factors associated with 1,25-dihydroxyvitamin D3 concentrations in liver transplant recipients: a prospective observational longitudinal study. | 2016 Apr |
2 |
| 88 |
26521259 | Population pharmacokinetics and pharmacogenetics of once daily tacrolimus formulation in stable liver transplant recipients. | 2016 Feb |
1 |
| 89 |
26651976 | Influence of CYP3A5 polymorphism on the pharmacokinetics of psychiatric drugs. | 2016 |
1 |
| 90 |
26924289 | Prediction of tacrolimus metabolism and dosage requirements based on CYP3A4 phenotype and CYP3A5(*)3 genotype in Chinese renal transplant recipients. | 2016 Apr |
2 |
| 91 |
27225724 | Effects of Genetic Polymorphism in CYP3A4 and CYP3A5 Genes on Tacrolimus Dose Among Kidney Transplant Recipients. | 2016 May |
5 |
| 92 |
27310200 | Risk Assessment of Drug-Drug Interactions of Calcineurin Inhibitors Affecting Sirolimus Pharmacokinetics in Renal Transplant Patients. | 2016 Oct |
1 |
| 93 |
27314545 | CYP3A pharmacogenetics and tacrolimus disposition in adult heart transplant recipients. | 2016 Sep |
3 |
| 94 |
27399255 | Drug interaction between dabrafenib and immunosuppressive drugs: about one case. | 2016 Oct |
1 |
| 95 |
25271728 | Which Genetic Determinants Should be Considered for Tacrolimus Dose Optimization in Kidney Transplantation? A Combined Analysis of Genes Affecting the CYP3A Locus. | 2015 Jun |
1 |
| 96 |
25287072 | The CYP3A4*22 C>T single nucleotide polymorphism is associated with reduced midazolam and tacrolimus clearance in stable renal allograft recipients. | 2015 Apr |
2 |
| 97 |
25588704 | Kidney transplant recipients carrying the CYP3A4*22 allelic variant have reduced tacrolimus clearance and often reach supratherapeutic tacrolimus concentrations. | 2015 Mar |
2 |
| 98 |
25600613 | In vitro-in vivo extrapolations to evaluate the effect of concomitant drugs on tacrolimus (FK506) exposure. | 2015 Jul |
3 |
| 99 |
25877445 | Reversible, time-dependent inhibition of CYP3A-mediated metabolism of midazolam and tacrolimus by telaprevir in human liver microsomes. | 2015 |
2 |
| 100 |
25881619 | Lack of a significant pharmacokinetic interaction between maraviroc and tacrolimus in allogeneic HSCT recipients. | 2015 Jul |
1 |